Records containing: Islet Cell Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-09Biospecimen Resource for Pancreas Disease, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease
-
CLINICAL_TRIALS study record update · 2019-12-26A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-08-25Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization
-
CLINICAL_TRIALS study record update · 2016-12-20A Randomized, Open-label Phase II Multicenter Study Evaluating the Efficacy of Oral Everolimus Alone or in Combination With Pasireotide LAR i.m. in Advanced Progressive Pancreatic Neuroendocrine Tumors (PNET) - The COOPERATE-2 Study
-
CLINICAL_TRIALS study record update · 2016-06-21A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-05-30Study of First-Line Therapy Comprising Leucovorin Calcium, Fluorouracil, and Irinotecan (FOLFIRI) in Patients With Progressive Locally Advanced or Metastatic Duodenal-Pancreatic Endocrine Tumors
-
CLINICAL_TRIALS study record update · 2015-06-04A Phase II Clinical and Biologic Study of AMG 706 and Octreotide in Patients With Low-Grade Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2014-07-02A Phase I Study of [111In-DTPA-D-Phe]-Octreotide in Patients With Refractory Malignancies Expressing Somatostatin Receptors
-
CLINICAL_TRIALS study record update · 2014-01-1768Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2013-10-29Clinical and Psychometric Validation of a Disease-Specific Questionnaire Module in Assessing the Quality of Life of Patients With G.I.-Related Neuroendocrine Tumours
-
CLINICAL_TRIALS study record update · 2013-08-07A Randomised Phase II Study Comparing Capecitabine Plus Streptozocin With or Without Cisplatin Chemotherapy as Treatment for Unresectable or Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2013-06-18Phase II Trial Of Thalidomide In Patients With Low Grade Neuroendocrine Tumors (Carcinoid and Islet Cell Cancers)
-
CLINICAL_TRIALS study record update · 2013-05-01A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors
-
CLINICAL_TRIALS study record update · 2013-01-31Phase II Study of PS-341 in Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-09-07Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Gastrointestinal Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-05-18Clinical Trial of Sir-Spheres® in Patients With Symptomatic or Progressive Hepatic Metastases From Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-03-23A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan for Metastatic Unresectable Cancers of the Liver